List of Xeris Pharmaceuticals, Inc. patents

Patents where

Current Assignee

Name

‌

Xeris Pharmaceuticals, Inc.

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11446310 Stable formulations for parenteral injection of small molecule drugs		‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	11446310	September 20, 2022
‌ US Patent 9642894 Compositions for rapidly treating severe hypoglycemia	Patent 9642894 was granted and assigned to Xeris Pharmaceuticals, Inc. on May, 2017 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	9642894	May 9, 2017
‌ US Patent 11590205 Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents	Patent 11590205 was granted and assigned to Xeris Pharmaceuticals, Inc. on February, 2023 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	11590205	February 28, 2023
‌ US Patent 9649364 Methods for producing stable therapeutic formulations in aprotic polar solvents	Patent 9649364 was granted and assigned to Xeris Pharmaceuticals, Inc. on May, 2017 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	9649364	May 16, 2017
‌ US Patent 9339545 Stable formulations for parenteral injection of peptide drugs	Patent 9339545 was granted and assigned to Xeris Pharmaceuticals, Inc. on May, 2016 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	9339545	May 17, 2016
‌ US Patent 10485850 Methods for producing stable therapeutic formulations in aprotic polar solvents	Patent 10485850 was granted and assigned to Xeris Pharmaceuticals, Inc. on November, 2019 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	10485850	November 26, 2019
‌ US Patent 9138479 Formulations for the treatment of diabetes	Patent 9138479 was granted and assigned to Xeris Pharmaceuticals, Inc. on September, 2015 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	9138479	September 22, 2015
‌ US Patent 8110209 Intracutaneous injection	Patent 8110209 was granted and assigned to Xeris Pharmaceuticals, Inc. on February, 2012 by the United States Patent and Trademark Office.		‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	8110209	February 7, 2012
‌ US Patent 9125805 Stable formulations for parenteral injection of small molecule drugs	Patent 9125805 was granted and assigned to Xeris Pharmaceuticals, Inc. on September, 2015 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	9125805	September 8, 2015
‌ US Patent 9302010 Stable formulations for parenteral injection of peptide drugs	Patent 9302010 was granted and assigned to Xeris Pharmaceuticals, Inc. on April, 2016 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	9302010	April 5, 2016
‌ US Patent 9314424 Pastes for injection of a therapeutic agent	Patent 9314424 was granted and assigned to Xeris Pharmaceuticals, Inc. on April, 2016 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	9314424	April 19, 2016
‌ US Patent 11020403 Precipitation resistant small molecule drug formulations	Patent 11020403 was granted and assigned to Xeris Pharmaceuticals, Inc. on June, 2021 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	11020403	June 1, 2021
‌ US Patent 9295724 Stable formulations for parenteral injection of peptide drugs	Patent 9295724 was granted and assigned to Xeris Pharmaceuticals, Inc. on March, 2016 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	9295724	March 29, 2016
‌ US Patent 9018162 Methods for rapidly treating severe hypoglycemia	Patent 9018162 was granted and assigned to Xeris Pharmaceuticals, Inc. on April, 2015 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	9018162	April 28, 2015
‌ US Patent 8697644 Stable formulations for parenteral injection of peptide drugs	Patent 8697644 was granted and assigned to Xeris Pharmaceuticals, Inc. on April, 2014 by the United States Patent and Trademark Office.		‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	8697644	April 15, 2014
‌ US Patent 10987399 Stable formulations for parenteral injection of peptide drugs	Patent 10987399 was granted and assigned to Xeris Pharmaceuticals, Inc. on April, 2021 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	10987399	April 27, 2021
‌ US Patent 10765683 Stable formulations for parenteral injection of small molecule drugs	Patent 10765683 was granted and assigned to Xeris Pharmaceuticals, Inc. on September, 2020 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	10765683	September 8, 2020
‌ US Patent 8790679 Intracutaneous paste composition	Patent 8790679 was granted and assigned to Xeris Pharmaceuticals, Inc. on July, 2014 by the United States Patent and Trademark Office.		‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	8790679	July 29, 2014
‌ US Patent 11129940 Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes	Patent 11129940 was granted and assigned to Xeris Pharmaceuticals, Inc. on September, 2021 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	11129940	September 28, 2021
‌ US Patent 11833157 Precipitation resistant small molecule drug formulations	Patent 11833157 was granted and assigned to Xeris Pharmaceuticals, Inc. on December, 2023 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	11833157	December 5, 2023
‌ US Patent 11964003 Stable sustained release therapeutic compositions in aprotic polar solvents and methods of manufacturing the same	Patent 11964003 was granted and assigned to Xeris Pharmaceuticals, Inc. on April, 2024 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	11964003	April 23, 2024
‌ US Patent 11576951 Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same	Patent 11576951 was granted and assigned to Xeris Pharmaceuticals, Inc. on February, 2023 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	11576951	February 14, 2023
‌ US Patent 11957736 Stable therapeutic compositions in aprotic polar solvents and methods of manufacturing the same	Patent 11957736 was granted and assigned to Xeris Pharmaceuticals, Inc. on April, 2024 by the United States Patent and Trademark Office.	‌ Xeris Pharmaceuticals, Inc.	‌ Xeris Pharmaceuticals, Inc.	United States Patent and Trademark Office	11957736	April 16, 2024

23 results

0 selected

23 results

0 selected